School of Medicine
Showing 861-880 of 1,140 Results
-
Maryam Rostami
Professional-NX, Psychiatry and Behavioral Sciences
BioMaryam Rostami is a professional data analyst in the Department of Psychiatry and Behavioral Science at Stanford university, currently working in the area of neuroethics and public health. She got a PhD in cognitive neuroscience and neuroimaging from Tohoku university/Japan that folloed by two years of research in the same area at Stanford university.
-
Walton T. Roth
Professor of Psychiatry & Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsLaboratory and ambulatory recording of physiological, responses to stressors in anxious and phobic patients.
-
Cristin Runfola
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Runfola's research focuses on the epidemiology of dysregulated eating and weight concerns in undeserved populations and her primary interest is in developing and testing the efficacy of clinical interventions designed to improve outcome for eating disorders.
With support from GFED, Dr. Runfola adapted the Uniting Couples in the treatment of Anorexia Nervosa (UCAN) therapy manual for couples in which one or both members have binge-eating disorder (UNITE) and recently completed pilot testing on this treatment. She is in the process of expanding this treatment for all couples affected by binge eating, and is submitting a grant to fund future work testing efficacy. -
Samuel Ricardo Saenz
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Sam Saenz was born in the Bay Area and received his bachelor’s degree in psychology from Stanford University. He completed his medical degree at UC Irvine’s Program in Medical Education for the Latino Community, and he also obtained a Master’s in Public Health from UC Berkeley. After serving as chief psychiatry resident during his psychiatry residency at Stanford, he completed a fellowship in public psychiatry at UC San Francisco. His professional interests include fostering the next generation of diverse mental health providers as well as advancing justice, equity, and inclusion (JEDI) work in academic medicine.
-
Debra Safer
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsPrimary research interests include the nature and treatment of eating disorders
(particularly bulimia nervosa and binge eating disorder), the development and treatment of obesity, and the development and treatment of problematic eating patterns in patients following bariatric surgery. -
Manish Saggar
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsWe are a computational neuropsychiatry lab dedicated to developing computational methods to better understand brain’s overall dynamical organization in healthy and patient populations. We employ algorithms from a wide range of fields, including Applied Mathematics, Econometrics, Machine Learning, Biophysics, and Network Science.
-
Gregory Lee Sahlem
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioDr.Sahlem is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences. He is board-certified in general psychiatry and addictions medicine, as well as fellowship-trained in the research and clinical application of neuromodulation-based treatments including repetitive Transcranial Magnetic Stimulation (rTMS), electroconvulsive therapy (ECT), and vagus nerve stimulation (VNS). He additionally has advanced training in the treatment of mood and sleep disorders. In addition to being an active clinician, Dr.Sahlem is a member of the Stanford Brain Stimulation Lab and directs the Addictions Research Section of the Lab.
Major areas of study for Dr.Sahlem include: The development of rTMS as a focused treatment for addictive disorders; the development of a novel form of ECT theorized to have reduced cognitive side effects, Focal Electrically Administered Seizure Therapy (FEAST), and; the further development of rTMS for the treatment of mood disorders. -
Khalid Salaheldin, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKhalid Salaheldin, MD, holds the position of Clinical Assistant Professor and serves as an interventional psychiatrist within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His expertise lies in the specialized care of individuals who present with early psychosis.
At Stanford, Dr. Salaheldin's current responsibilities encompass a range of clinical activities, including evaluating patients with early psychosis at the INSPIRE clinic, providing care in the inpatient psychiatric unit, and delivering interventional psychiatry services. In addition to his clinical work, he is actively engaged in teaching, conducting research, and fostering collaborative learning among his patients and colleagues.
His treatment philosophy is a recovery oriented and compassionate approach evaluating vital underlying factors alongside pharmacotherapy & neuromodulatory interventions including: sleep, exercise, nutrition, mindfulness, therapy integration, underlying medical issues, substance use, psychosocial history, and importantly patients’ current relationships (including pets of course!). His approach focuses on meeting patients where they are at in their health journey, aligning treatment with their personal goals, and being actively present in their management.
Dr. Salaheldin’s research interests include early psychosis interventions, underlying medical causes of psychiatric symptoms, neuromodulation, community/global mental health, spirituality and mental health, healthcare worker mental health, novel psychiatric therapeutics, and mental health parity & policy.
Before joining Stanford, Dr. Salaheldin served as the academic chief resident at Northwell Health, where his focus centered on designing a consult liaison service for patients experiencing a first episode of psychosis. This pioneering initiative aimed to provide compassionate support to patients and their families from the moment they arrived at the emergency room, throughout their inpatient stay, and during their transition to the outpatient setting. He hopes to continue this work on a local and global scale.
“True compassion means not only feeling another's pain, but also being moved to help relieve it. ” —Daniel Goleman